Prognostic significance of different molecular typing methods and immune status based on rna sequencing in hr-positive and her2-negative early-stage breast cancer

HIGHLIGHTS

• who: Xinyu Ren from the Department of Pathology, Molecular Pathology Research Centre, Peking District, Beijing, China have published the article: Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer, in the Journal: (JOURNAL)
• what: Background: This study was conducted to evaluate the prognostic significance of different molecular typing methods and immune status based on RNA sequencing (RNA-seq) in hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative (HR + /HER2-) early-stage breast and develop a . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.